Hideo Arai
Director/Board Member chez INA RESEARCH INC.
Fortune : 152 348 $ au 31/03/2024
Profil
Hideo Arai currently works at Oriental Yeast Co., Ltd., as Director & General Manager-Bioindustry Business from 1981, Ina Research, Inc., as Outside Director from 2019, and Kohjin Bio Co., Ltd., as Independent Outside Director from 2015.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Kohjin BIO Co., Ltd.
 Kohjin BIO Co., Ltd. BiotechnologyHealth Technology Kohjin Bio Co., Ltd. engages in the manufacture and sale of animal blood, serums, tissue culture media and other products. It operates through the following business segments. Tissue Culture Business, Microbiology Business and Cell Processing Business. The Tissue Culture business segment engages in the manufactures, and sale of tissue culture media, including serum free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions. The company was founded by Takato Nakamura in April 1981 and is headquartered in Sakado, Japan. 0,20% | 22/03/2024 | 10 000 ( 0,20% ) | 152 348 $ | 31/03/2024 |
Postes actifs de Hideo Arai
| Sociétés | Poste | Début |
|---|---|---|
| INA RESEARCH INC. | Director/Board Member | 01/06/2019 |
Oriental Yeast Co., Ltd.
 Oriental Yeast Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Oriental Yeast Co., Ltd. engages in the manufacture and sale of yeast, raw materials for bread manufacturing, confectionery, noodles, various feeds, biochemistry, and toxicity studies on medicines, food, and others. It is also engages in sales of laboratory animals. Its operations are carried out through the following segments: Food Business and Bioindustry Business. The Food Business segment develops and supplies food ingredients including yeast, flour paste, and mayonnaise. The Bioindustry Business segment produces diagnostic reagent raw materials or reagent in research use, including recombinant enzymes and human proteins. The company was founded on June 30, 1929 and is headquartered in Tokyo, Japan. | Director/Board Member | 28/04/2011 |
Kohjin BIO Co., Ltd.
Kohjin BIO Co., Ltd. BiotechnologyHealth Technology Kohjin Bio Co., Ltd. engages in the manufacture and sale of animal blood, serums, tissue culture media and other products. It operates through the following business segments. Tissue Culture Business, Microbiology Business and Cell Processing Business. The Tissue Culture business segment engages in the manufactures, and sale of tissue culture media, including serum free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions. The company was founded by Takato Nakamura in April 1981 and is headquartered in Sakado, Japan. | Director/Board Member | 01/06/2015 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
| Entreprise privées | 2 |
|---|---|
Oriental Yeast Co., Ltd.
Oriental Yeast Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Oriental Yeast Co., Ltd. engages in the manufacture and sale of yeast, raw materials for bread manufacturing, confectionery, noodles, various feeds, biochemistry, and toxicity studies on medicines, food, and others. It is also engages in sales of laboratory animals. Its operations are carried out through the following segments: Food Business and Bioindustry Business. The Food Business segment develops and supplies food ingredients including yeast, flour paste, and mayonnaise. The Bioindustry Business segment produces diagnostic reagent raw materials or reagent in research use, including recombinant enzymes and human proteins. The company was founded on June 30, 1929 and is headquartered in Tokyo, Japan. | Consumer Non-Durables |
Ina Research, Inc.
 Ina Research, Inc. Miscellaneous Commercial ServicesCommercial Services Ina Research, Inc. engages in the development of pharmaceutical products. It operates through Entrusted Testing and Environment segments. The Entrusted Testing segment covers the safe testing of pharmaceuticals, medical equipment, pesticides, food, and other chemicals and also handles the commissioned clinical trials for drug development. The Environment segment designs and sells deodorizing equipment, sterilization device, and related laboratory equipment. The company was founded on July 13, 1974 and is headquartered in Ina, Japan. | Commercial Services |
